news
New Frontiers article: examining chronic exposure to SARS-CoV-2
Crowdfunding the Long Covid Journey
EpitogenX and Attomarker Sign Strategic Co-Development Agreement
What an Acceleration Round means for Attomarker at this stage
Attomarker launches Acceleration Round
Attomarker has been selected as one of the companies by Innovate UK
Attomarker is Revolutionising Diagnostic Technology and the Potential of Big Data
Long Covid – can we weaken its grip?
Were White House COVID victims lulled into false sense of security by current antigen tests?
Hunting down the virus in the community will help resolve lab-based logjams and avoid lockdowns
Is Attomarker’s Triple Antibody Test for COVID-19 now the best by far?
Professor Andrew Shaw interviewed on television about Attomarker’s Triple Antibody Test
Attomarker’s Triple Antibody Test for COVID-19 authorised by the MHRA following positive trial results at St Thomas’ London
Attomarker’s rapid antibody technology has shown promising results in understanding COVID-19 in tests at St Thomas’ Hospital, London
COVID-19 – Attomarker technology currently being tested at St Thomas’s Hospital, London
The Dangers of Superbugs
Theranos is one to forget. Attomarker is one to remember. So why are they both ‘Ones to Watch’?
The world’s largest medicine galleries open at the Science Museum Saturday 16th November, and Attomarker is there
Attomarker wins the ‘One to Watch’ award at the UK’s prestigious OBN Life Sciences event in Oxford
Attomarker the only British diagnostic device on show at the New York AMR summit, being held around the UN General Assembly opening, September 23rd, 2019
Attomarker invited to India to help in the fight against antimicrobial resistance
Load More
Long Covid – can we weaken its grip?
Were White House COVID victims lulled into false sense of security by current antigen tests?
Hunting down the virus in the community will help resolve lab-based logjams and avoid lockdowns
Is Attomarker’s Triple Antibody Test for COVID-19 now the best by far?
Professor Andrew Shaw interviewed on television about Attomarker’s Triple Antibody Test
Attomarker’s Triple Antibody Test for COVID-19 authorised by the MHRA following positive trial results at St Thomas’ London
Attomarker’s rapid antibody technology has shown promising results in understanding COVID-19 in tests at St Thomas’ Hospital, London
COVID-19 – Attomarker technology currently being tested at St Thomas’s Hospital, London
The Dangers of Superbugs
Theranos is one to forget. Attomarker is one to remember. So why are they both ‘Ones to Watch’?
The world’s largest medicine galleries open at the Science Museum Saturday 16th November, and Attomarker is there
Attomarker wins the ‘One to Watch’ award at the UK’s prestigious OBN Life Sciences event in Oxford
Attomarker the only British diagnostic device on show at the New York AMR summit, being held around the UN General Assembly opening, September 23rd, 2019
Attomarker invited to India to help in the fight against antimicrobial resistance
Load More